| The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein P Neviani, R Santhanam, R Trotta, M Notari, BW Blaser, S Liu, H Mao, ... Cancer cell 8 (5), 355-368, 2005 | 599 | 2005 |
| Preclinical characterization of 1-7F9, a novel human anti–KIR receptor therapeutic antibody that augments natural killer–mediated killing of tumor cells F Romagné, P André, P Spee, S Zahn, N Anfossi, L Gauthier, M Capanni, ... Blood, The Journal of the American Society of Hematology 114 (13), 2667-2677, 2009 | 489 | 2009 |
| FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemia P Neviani, R Santhanam, JJ Oaks, AM Eiring, M Notari, BW Blaser, S Liu, ... The Journal of clinical investigation 117 (9), 2408-2421, 2007 | 433 | 2007 |
| Pro-and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells J Yu, M Wei, B Becknell, R Trotta, S Liu, Z Boyd, MS Jaung, BW Blaser, ... Immunity 24 (5), 575-590, 2006 | 309 | 2006 |
| A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation M Notari, P Neviani, R Santhanam, BW Blaser, JS Chang, A Galietta, ... Blood 107 (6), 2507-2516, 2006 | 238 | 2006 |
| Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia L Wang, J Wang, BW Blaser, AM Duchemin, DF Kusewitt, T Liu, ... Blood, The Journal of the American Society of Hematology 110 (6), 2075-2083, 2007 | 147 | 2007 |
| Tumor growth impedes natural-killer-cell maturation in the bone marrow JO Richards, X Chang, BW Blaser, MA Caligiuri, P Zheng, Y Liu Blood 108 (1), 246-252, 2006 | 109 | 2006 |
| Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease BW Blaser, S Roychowdhury, DJ Kim, NR Schwind, D Bhatt, W Yuan, ... Blood 105 (2), 894-901, 2005 | 92 | 2005 |
| In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis M Guimond, AG Freud, HC Mao, J Yu, BW Blaser, JW Leong, ... The Journal of Immunology 184 (6), 2769-2775, 2010 | 79 | 2010 |
| CD200 promotes immunosuppression in the pancreatic tumor microenvironment F Choueiry, M Torok, R Shakya, K Agrawal, A Deems, B Benner, A Hinton, ... Journal for immunotherapy of cancer 8 (1), 2020 | 77 | 2020 |
| The PP2A inhibitor SET regulates natural killer cell IFN-γ production R Trotta, D Ciarlariello, JD Col, J Allard, P Neviani, R Santhanam, H Mao, ... The Journal of experimental medicine 204 (10), 2397-2405, 2007 | 74 | 2007 |
| IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease S Roychowdhury, BW Blaser, AG Freud, K Katz, D Bhatt, AK Ferketich, ... Blood 106 (7), 2433-2435, 2005 | 68 | 2005 |
| Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantation BW Blaser, HT Kim, EP Alyea III, VT Ho, C Cutler, P Armand, J Koreth, ... Biology of Blood and Marrow Transplantation 18 (4), 575-583, 2012 | 55 | 2012 |
| CXCR1 remodels the vascular niche to promote hematopoietic stem and progenitor cell engraftment BW Blaser, JL Moore, EJ Hagedorn, B Li, R Riquelme, A Lichtig, S Yang, ... Journal of Experimental Medicine 214 (4), 1011-1027, 2017 | 52 | 2017 |
| New directions in natural killer cell-based immunotherapy of human cancer SS Farag, TA Fehniger, B Becknell, BW Blaser, MA Caligiuri Expert opinion on biological therapy 3 (2), 237-250, 2003 | 51 | 2003 |
| STAT‐1‐mediated repression of monocyte interleukin‐10 gene expression in vivo JB VanDeusen, MH Shah, B Becknell, BW Blaser, AK Ferketich, ... European journal of immunology 36 (3), 623-630, 2006 | 48 | 2006 |
| Preclinical Assessment of FHIT Gene Replacement Therapy in Human Leukemia Using a Chimeric Adenovirus, Ad5/F35 F Pichiorri, F Trapasso, T Palumbo, RI Aqeilan, A Drusco, BW Blaser, ... Clinical cancer research 12 (11), 3494-3501, 2006 | 42 | 2006 |
| Selective Efficacy of Depsipeptide in a Xenograft Model of Epstein-Barr Virus–Positive Lymphoproliferative Disorder S Roychowdhury, RA Baiocchi, S Vourganti, D Bhatt, BW Blaser, ... Journal of the National Cancer Institute 96 (19), 1447-1457, 2004 | 38 | 2004 |
| Hlx homeobox transcription factor negatively regulates interferon-γ production in monokine-activated natural killer cells B Becknell, TL Hughes, AG Freud, BW Blaser, J Yu, R Trotta, HC Mao, ... Blood 109 (6), 2481-2487, 2007 | 35 | 2007 |
| Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity BW Blaser, NR Schwind, S Karol, D Chang, S Shin, S Roychowdhury, ... Blood 108 (7), 2463-2469, 2006 | 33 | 2006 |
